Trexquant Investment’s Aratana Therapeutics, Inc. PETX Stock Holding History

Trexquant Investment’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-29,546	Closed	-$181K	–	1471
2018 Q4	$181K	Buy	+29,546	New	+$180K	0.01%	934
2017 Q3	–	Sell	-31,549	Closed	-$228K	–	1155
2017 Q2	$228K	Buy	+31,549	New	+$194K	0.06%	608
2016 Q3	–	Sell	-29,776	Closed	-$188K	–	1125
2016 Q2	$188K	Buy	+29,776	New	+$192K	0.02%	782
2016 Q1	–	Sell	-114,900	Closed	-$641K	–	1291
2015 Q4	$641K	Buy	114,900 +72,400	+170%	+$478K	0.06%	582
2015 Q3	$359K	Sell	42,500 -2,100	-5%	-$35.5K	0.03%	829
2015 Q2	$674K	Buy	+44,600	New	+$644K	0.08%	500

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Trexquant Investment's PETX Position: Q1 2019 in Review

Trexquant Investment sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 29,546 shares — an estimated $181K sold.

Trexquant Investment first reported a position in PETX in Q2 2015 and held it in 6 quarters. The position peaked at $674K in Q2 2015. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

Trexquant Investment reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Trexquant Investment sold 29,546 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $181K.
Trexquant Investment first reported a position in Aratana Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
Trexquant Investment's Aratana Therapeutics, Inc. position peaked at $674K in Q2 2015.
104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.